Design and Reporting of Prebiotic and Probiotic Clinical Trials in the Context of Diet and the Gut Microbiome
Overview
Authors
Affiliations
Diet is a major determinant of the gastrointestinal microbiome composition and function, yet our understanding of how it impacts the efficacy of prebiotics and probiotics is limited. Here we examine current evidence of dietary influence on prebiotic and probiotic efficacy in human studies, including potential mechanisms. We propose that habitual diet be included as a variable in prebiotic and probiotic intervention studies. This recommendation is based on the potential mechanisms via which diet can affect study outcomes, either directly or through the gut microbiome. We consider the challenges and opportunities of dietary assessment in this context. Lastly, we provide recommendations for the design, conduct and reporting of human clinical trials of prebiotics and probiotics (and other biotic interventions) to account for any effect of diet and nutrition.
The Interplay of Nutrition, the Gut Microbiota and Immunity and Its Contribution to Human Disease.
Dawson S, Todd E, Ward A Biomedicines. 2025; 13(2).
PMID: 40002741 PMC: 11853302. DOI: 10.3390/biomedicines13020329.
Gut microbiota interact with breast cancer therapeutics to modulate efficacy.
Arnone A, Ansley K, Heeke A, Howard-McNatt M, Cook K EMBO Mol Med. 2025; 17(2):219-234.
PMID: 39820166 PMC: 11822015. DOI: 10.1038/s44321-024-00185-0.